COVID‐19 and the Otolaryngologist: Preliminary Evidence‐Based Review

  • Neelaysh Vukkadala
    Department of Otolaryngology–Head and Neck Surgery Stanford University School of Medicine Stanford California U.S.A.
  • Z. Jason Qian
    Department of Otolaryngology–Head and Neck Surgery Stanford University School of Medicine Stanford California U.S.A.
  • F. Christopher Holsinger
    Department of Otolaryngology–Head and Neck Surgery Stanford University School of Medicine Stanford California U.S.A.
  • Zara M. Patel
    Department of Otolaryngology–Head and Neck Surgery Stanford University School of Medicine Stanford California U.S.A.
  • Eben Rosenthal
    Department of Otolaryngology–Head and Neck Surgery Stanford University School of Medicine Stanford California U.S.A.

書誌事項

公開日
2020-04-24
権利情報
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1002/lary.28672
公開者
Wiley

この論文をさがす

説明

<jats:p>The SARS‐CoV‐2 virus, which causes coronavirus disease 2019 (COVID‐19), has rapidly swept across the world since its identification in December 2019. Otolaryngologists are at unique risk due to the close contact with mucus membranes of the upper respiratory tract and have been among the most affected healthcare workers in Wuhan, China. We present information on COVID‐19 management relevant to otolaryngologists on the frontlines of this pandemic and provide preliminary guidance based on practices implemented in China and other countries and practical strategies deployed at Stanford University. <jats:italic>Laryngoscope</jats:italic>, 130:2537–2543, 2020</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ